The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
27836398 |
31 |
Discovery of 1,3-diethyl-7-methyl-8-(phenoxymethyl)-xanthine derivatives as novel adenosine A |
North-West University |
27933810 |
166 |
Structure-Based Scaffold Repurposing for G Protein-Coupled Receptors: Transformation of Adenosine Derivatives into 5HT |
National Institute of Diabetes and Digestive and Kidney Diseases |
27485602 |
183 |
Similarities and differences in affinity and binding modes of tricyclic pyrimido- and pyrazinoxanthines at human and rat adenosine receptors. |
Jagiellonian University Medical College |
26776359 |
21 |
Carbamate substituted 2-amino-4,6-diphenylpyrimidines as adenosine receptor antagonists. |
North-West University |
26781932 |
109 |
Discovery of aminoquinazoline derivatives as human A(2A) adenosine receptor antagonists. |
Merck Research Laboratories |
26392370 |
66 |
1,3,7-Triethyl-substituted xanthines--possess nanomolar affinity for the adenosine A1 receptor. |
North-West University |
25915162 |
12 |
New Frontiers in Selective Human MAO-B Inhibitors. |
Sapienza University of Rome |
24815000 |
21 |
8-Substituted 2-alkynyl-N(9)-propargyladenines as A2A adenosine receptor antagonists. |
Yamasa |
24164628 |
186 |
Adenosine A2A receptor as a drug discovery target. |
Merck Research Laboratories |
9438021 |
97 |
Flavonoid derivatives as adenosine receptor antagonists: a comparison of the hypothetical receptor binding site based on a comparative molecular field analysis model. |
National Institute of Diabetes |
23245803 |
87 |
Synthesis and structure-activity relationships of 2-hydrazinyladenosine derivatives as A(2A) adenosine receptor ligands. |
University of Bonn |
23281824 |
118 |
Synthesis of (E)-8-(3-chlorostyryl)caffeine analogues leading to 9-deazaxanthine derivatives as dual A(2A) antagonists/MAO-B inhibitors. |
Universit£ |
16392813 |
329 |
Design, synthesis, and structure-activity relationships of 1-,3-,8-, and 9-substituted-9-deazaxanthines at the human A2B adenosine receptor. |
Universit£ |
22468757 |
171 |
Medicinal chemistry of A3 adenosine receptor modulators: pharmacological activities and therapeutic implications. |
Universit£ |
21664729 |
142 |
Synthesis and biological activity of tricyclic cycloalkylimidazo-, pyrimido- and diazepinopurinediones. |
Jagiellonian University Medical College |
22486652 |
44 |
Optimization of adenosine 5'-carboxamide derivatives as adenosine receptor agonists using structure-based ligand design and fragment screening. |
National Institute of Diabetes and Digestive and Kidney Diseases |
24900277 |
36 |
Development of Polar Adenosine A2A Receptor Agonists for Inflammatory Bowel Disease: Synergism with A2B Antagonists. |
TBA |
20188574 |
141 |
2-Amino-5-benzoyl-4-phenylthiazoles: Development of potent and selective adenosine A1 receptor antagonists. |
University of Bonn |
19569717 |
251 |
1-alkyl-8-(piperazine-1-sulfonyl)phenylxanthines: development and characterization of adenosine A2B receptor antagonists and a new radioligand with subnanomolar affinity and subtype specificity. |
Institute |
18424135 |
131 |
Design of (N)-methanocarba adenosine 5'-uronamides as species-independent A3 receptor-selective agonists. |
National Institute of Diabetes and Digestive and Kidney Diseases |
15566292 |
153 |
Novel bicyclic piperazine derivatives of triazolotriazine and triazolopyrimidines as highly potent and selective adenosine A2A receptor antagonists. |
Biogen Idec |
15771453 |
22 |
Development of spin-labeled probes for adenosine receptors. |
University of Bonn |
15771443 |
94 |
Novel diamino derivatives of [1,2,4]triazolo[1,5-a][1,3,5]triazine as potent and selective adenosine A2a receptor antagonists. |
Biogen Idec |
15267242 |
54 |
Synthesis and biological activity of new potential agonists for the human adenosine A2A receptor. |
Iiqab (Csic) |
15084123 |
24 |
Novel amino acid derived natural products from the ascidian Atriolum robustum: identification and pharmacological characterization of a unique adenosine derivative. |
University of Bonn |
12646033 |
124 |
Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists. |
Universit£ |
11881988 |
16 |
Ribose-modified nucleosides as ligands for adenosine receptors: synthesis, conformational analysis, and biological evaluation of 1'-C-methyl adenosine analogues. |
Universit£ |
11784146 |
9 |
2,5'-Disubstituted adenosine derivatives: evaluation of selectivity and efficacy for the adenosine A(1), A(2A), and A(3) receptor. |
Leiden/Amsterdam Center For Drug Research |
12139454 |
56 |
Imidazo[2,1-i]purin-5-ones and related tricyclic water-soluble purine derivatives: potent A(2A)- and A(3)-adenosine receptor antagonists. |
University of Bonn |
11262085 |
92 |
Thiazole and thiadiazole analogues as a novel class of adenosine receptor antagonists. |
Vrije Universiteit |
11170643 |
171 |
Design, synthesis, and evaluation of novel A2A adenosine receptor agonists. |
University of Virginia |
11708915 |
52 |
Neoceptor concept based on molecular complementarity in GPCRs: a mutant adenosine A(3) receptor with selectively enhanced affinity for amine-modified nucleosides. |
National Institute of Diabetes and Digestive and Kidney Diseases |
11170630 |
46 |
Nucleosides and nucleotides. 200. Reinvestigation of 5'-N-ethylcarboxamidoadenosine derivatives: structure-activity relationships for P(3) purinoceptor-like proteins. |
Hokkaido University |
10649980 |
52 |
N-cycloalkyl derivatives of adenosine and 1-deazaadenosine as agonists and partial agonists of the A(1) adenosine receptor. |
Universit£ |
10841798 |
64 |
Methanocarba analogues of purine nucleosides as potent and selective adenosine receptor agonists. |
National Institute of Diabetes |
10821712 |
18 |
Quantized surface complementarity diversity (QSCD): a model based on small molecule-target complementarity. |
Neogenesis |
10212125 |
14 |
N6,5'-Disubstituted adenosine derivatives as partial agonists for the human adenosine A3 receptor. |
Leiden/Amsterdam Center For Drug Research |
10212124 |
26 |
5'-N-substituted carboxamidoadenosines as agonists for adenosine receptors. |
Leiden University |
9703464 |
40 |
Structure-activity relationships and molecular modeling of 3, 5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists. |
National Institute of Diabetes |
9703463 |
102 |
Synthesis and biological activity of a new series of N6-arylcarbamoyl, 2-(Ar)alkynyl-N6-arylcarbamoyl, and N6-carboxamido derivatives of adenosine-5'-N-ethyluronamide as A1 and A3 adenosine receptor agonists. |
Universit£ |
9667957 |
5 |
Nucleosides and nucleotides. 177. 9-(6,7-dideoxy-beta-D-allo-hept-5- ynofuranosyl)adenine: a selective and potent ligand for P3 purinoceptor-like protein. |
Hokkaido University |
9438026 |
41 |
5'-substituted adenosine analogs as new high-affinity partial agonists for the adenosine A1 receptor. |
Leiden/Amsterdam Center For Drug Research |
9371242 |
54 |
N6-cyclopentyl-3'-substituted-xylofuranosyladenosines: a new class of non-xanthine adenosine A1 receptor antagonists. |
University of Ghent |
8576924 |
69 |
Novel N6-(substituted-phenylcarbamoyl)adenosine-5'-uronamides as potent agonists for A3 adenosine receptors. |
Universit£ |
8917655 |
72 |
6-phenyl-1,4-dihydropyridine derivatives as potent and selective A3 adenosine receptor antagonists. |
National Institute of Diabetes |
8863798 |
52 |
2-alkenyl and 2-alkyl derivatives of adenosine and adenosine-5'-N-ethyluronamide: different affinity and selectivity of E- and Z-diastereomers at A2A adenosine receptors. |
Universit£ |
8709132 |
92 |
Interaction of 1,4-dihydropyridine and pyridine derivatives with adenosine receptors: selectivity for A3 receptors. |
National Institute of Diabetes |
7739005 |
143 |
2-Aralkynyl and 2-heteroalkynyl derivatives of adenosine-5'-N-ethyluronamide as selective A2a adenosine receptor agonists. |
Universit£ |
7707320 |
99 |
Search for new purine- and ribose-modified adenosine analogues as selective agonists and antagonists at adenosine receptors. |
National Institute of Diabetes |
7562934 |
38 |
Ribose-modified adenosine analogues as potential partial agonists for the adenosine receptor. |
Leiden University |
7658444 |
56 |
2-[N'-(3-arylallylidene)hydrazino]adenosines showing A2a adenosine agonist properties and vasodilation activity. |
Universit£ |
7752196 |
103 |
Structure-activity relationships of 9-alkyladenine and ribose-modified adenosine derivatives at rat A3 adenosine receptors. |
National Institute of Diabetes |
7966162 |
39 |
Selective ligands for rat A3 adenosine receptors: structure-activity relationships of 1,3-dialkylxanthine 7-riboside derivatives. |
National Institute of Diabetes |
7932588 |
48 |
2-Substitution of N6-benzyladenosine-5'-uronamides enhances selectivity for A3 adenosine receptors. |
National Institute of Diabetes |
1495019 |
57 |
Nucleosides and nucleotides. 112. 2-(1-Hexyn-1-yl)adenosine-5'-uronamides: a new entry of selective A2 adenosine receptor agonists with potent antihypertensive activity. |
Hokkaido University |
1766003 |
18 |
Activity of N6-substituted 2-chloroadenosines at A1 and A2 adenosine receptors. |
University of South Florida |
12617898 |
13 |
Design, synthesis and binding affinity of 3'-fluoro analogues of Cl-IB-MECA as adenosine A3 receptor ligands. |
Seoul National University |
11392549 |
45 |
Ring-Constrained (N)-methanocarba nucleosides as adenosine receptor agonists: independent 5'-uronamide and 2'-deoxy modifications. |
Niddk |
10714510 |
36 |
The discovery and synthesis of highly potent, A2a receptor agonists. |
Glaxowellcome Medicines Research Centre |
10999489 |
29 |
2-Nitro analogues of adenosine and 1-deazaadenosine: synthesis and binding studies at the adenosine A1, A2A and A3 receptor subtypes. |
University of Amsterdam |
9871585 |
23 |
Diimidazo[1,2-c:4',5'-e]pyrimidines: N6-N1 conformationally restricted adenosines. |
Griffith University |
| 31 |
New base-altered adenosine analogues: Synthesis and affinity at adenosine A1 and A2A receptors |
TBA |
22104008 |
64 |
Evaluation of molecular modeling of agonist binding in light of the crystallographic structure of an agonist-bound A2A adenosine receptor. |
National Institute of Diabetes and Digestive and Kidney Diseases |
20869242 |
46 |
Discovery of 2-aminoimidazopyridine adenosine A(2A) receptor antagonists. |
Ligand Pharmaceuticals |
20537438 |
101 |
Insights into binding modes of adenosine A(2B) antagonists with ligand-based and receptor-based methods. |
East China University of Science and Technology |
20116907 |
15 |
Synthesis and theoretical studies on energetics of novel N- and O- perfluoroalkyl triazole tagged thienopyrimidines--their potential as adenosine receptor ligands. |
Institute of Chemical Technology |
20304654 |
79 |
Synthesis and pharmacological characterization of a new series of 5,7-disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazine derivatives as adenosine receptor antagonists: A preliminary inspection of ligand-receptor recognition process. |
National University of Singapore |
19580286 |
44 |
Nucleoside-5'-monophosphates as prodrugs of adenosine A2A receptor agonists activated by ecto-5'-nucleotidase. |
University of Bonn |
| 52 |
Adenosine A2A antagonists with potent anti-cataleptic activity |
TBA |
| 8 |
Pyrazolo[3,4-d]pyrimidines: C4, C6 substitution leads to adenosine A1 receptor selectivity |
TBA |
| 12 |
Pyrazolo[3,4-d]pyrimidines; adenosine receptor selectivity |
TBA |
| 32 |
Synthesis of new pyrazolo[4,3-e]1,2,4-triazolo[1,5-c] pyrimidine and 1,2,3-triazolo[4,5-e]1,2,4-triazolo[1,5-c] pyrimidine displaying potent and selective activity as A2a adenosine receptor antagonists. |
TBA |
19140664 |
82 |
N-[6-amino-2-(heteroaryl)pyrimidin-4-yl]acetamides as A2A receptor antagonists with improved drug like properties and in vivo efficacy. |
Neurocrine Biosciences |
18835161 |
37 |
2,6-Diaryl-4-acylaminopyrimidines as potent and selective adenosine A(2A) antagonists with improved solubility and metabolic stability. |
Neurocrine Biosciences |
18723354 |
12 |
Dual inhibition of monoamine oxidase B and antagonism of the adenosine A(2A) receptor by (E,E)-8-(4-phenylbutadien-1-yl)caffeine analogues. |
North-West University |
17602796 |
5 |
Synthesis and adenosine receptor binding studies of some novel triazolothienopyrimidines. |
University College of Pharmaceutical Sciences |
12398547 |
9 |
Lignans isolated from valerian: identification and characterization of a new olivil derivative with partial agonistic activity at A(1) adenosine receptors. |
University of Bonn |
9514015 |
6 |
Bioactive pyridoacridine alkaloids from the micronesian sponge Oceanapia sp. |
Institut FüR Biowissenschaften |
18329269 |
77 |
Synthesis of N-pyrimidinyl-2-phenoxyacetamides as adenosine A2A receptor antagonists. |
Neurocrine Biosciences |
18189346 |
21 |
Identification of novel, water-soluble, 2-amino-N-pyrimidin-4-yl acetamides as A2A receptor antagonists with in vivo efficacy. |
Neurocrine Biosciences |
17827019 |
86 |
Phenylethyl-substituted pyrimido[2,1-f]purinediones and related compounds: structure-activity relationships as adenosine A(1) and A(2A) receptor ligands. |
Jagiellonian University Medical College |
17499511 |
46 |
N9-benzyl-substituted 1,3-dimethyl- and 1,3-dipropyl-pyrimido[2,1-f]purinediones: synthesis and structure-activity relationships at adenosine A1 and A2A receptors. |
Jagiellonian University |
17381154 |
4 |
Neuroprotective principles from Gastrodia elata. |
National Research Institute of Chinese Medicine |
17236762 |
23 |
Potent, selective, and orally active adenosine A2A receptor antagonists: arylpiperazine derivatives of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines. |
Schering-Plough Research Institute |
17125265 |
49 |
Tricyclic imidazoline derivatives as potent and selective adenosine A1 receptor antagonists. |
Biogen Idec |
17125264 |
60 |
Potent and orally bioavailable 8-bicyclo[2.2.2]octylxanthines as adenosine A1 receptor antagonists. |
Biogen Idec |
16821798 |
62 |
A new synthesis of sulfonamides by aminolysis of p-nitrophenylsulfonates yielding potent and selective adenosine A2B receptor antagonists. |
University of Bonn |
16153830 |
64 |
Synthesis of [1,2,4]triazolo[1,5-a]pyrazines as adenosine A2A receptor antagonists. |
Biogen Idec |
15978806 |
40 |
2-(2-Furanyl)-7-phenyl[1,2,4]triazolo[1,5-c]pyrimidin-5-amine analogs: highly potent, orally active, adenosine A2A antagonists. Part 1. |
Schering-Plough Research Institute |
15664803 |
46 |
Synthesis of alkyne derivatives of a novel triazolopyrazine as A(2A) adenosine receptor antagonists. |
Biogen Idec |
15341934 |
28 |
Triamino derivatives of triazolotriazine and triazolopyrimidine as adenosine A2a receptor antagonists. |
Biogen Idec |
15341933 |
40 |
Studies on adenosine A2a receptor antagonists: comparison of three core heterocycles. |
Biogen Idec |
15294001 |
88 |
Piperazine derivatives of [1,2,4]triazolo[1,5-a][1,3,5]triazine as potent and selective adenosine A2a receptor antagonists. |
Biogen Idec |
14761205 |
56 |
Preparation, properties, reactions, and adenosine receptor affinities of sulfophenylxanthine nitrophenyl esters: toward the development of sulfonic acid prodrugs with peroral bioavailability. |
University of Bonn |
14741297 |
46 |
Synthesis and SAR evaluation of 1,2,4-triazoles as A(2A) receptor antagonists. |
F. Hoffmann-La Roche |
12270178 |
74 |
Structure-affinity relationships of the affinity of 2-pyrazolyl adenosine analogues for the adenosine A2A receptor. |
Cv Therapeutics |
12166943 |
81 |
1,2,4-Triazolo[5,1-i]purine derivatives as highly potent and selective human adenosine A(3) receptor ligands. |
Nutrition Research Institute |
12166930 |
21 |
Synthesis, biological properties, and molecular modeling investigation of the first potent, selective, and water-soluble human A(3) adenosine receptor antagonist. |
TBA |
12014951 |
139 |
Structure-activity relationships at human and rat A2B adenosine receptors of xanthine derivatives substituted at the 1-, 3-, 7-, and 8-positions. |
National Institute of Diabetes & Digestive & Kidney Diseases |
11960496 |
50 |
5'-Deoxy congeners of 9-(3-amido-3-deoxy-beta-D-xylofuranosyl)-N(6)-cyclopentyladenine: new adenosine A(1) receptor antagonists and inverse agonists. |
Ghent University |
11906291 |
129 |
1,8-disubstituted xanthine derivatives: synthesis of potent A2B-selective adenosine receptor antagonists. |
University of Bonn |
11454470 |
17 |
Substituted 4-phenyl-2-(phenylcarboxamido)-1,3-thiazole derivatives as antagonists for the adenosine A(1) receptor. |
Leiden/Amsterdam Center For Drug Research |
32631506 |
63 |
C2-substituted quinazolinone derivatives exhibit A |
North-West University |
11206456 |
7 |
High-pressure synthesis of enantiomerically pure C-6 substituted pyrazol. |
Astrazeneca R&D Griffith University |
11150167 |
28 |
Fluorosulfonyl-substituted xanthines as selective irreversible antagonists for the A(1)-adenosine receptor. |
Deakin University |
11101355 |
26 |
7-Deazaadenines bearing polar substituents: structure-activity relationships of new A(1) and A(3) adenosine receptor antagonists. |
University of Leipzig |
11087559 |
7 |
Design, radiosynthesis, and biodistribution of a new potent and selective ligand for in vivo imaging of the adenosine A(2A) receptor system using positron emission tomography. |
University of Milano-Bicocca |
30808606 |
240 |
Novel multi-target directed ligands based on annelated xanthine scaffold with aromatic substituents acting on adenosine receptor and monoamine oxidase B. Synthesis, in vitro and in silico studies. |
Jagiellonian University Medical College |
27658798 |
376 |
8-Substituted 1,3-dimethyltetrahydropyrazino[2,1-f]purinediones: Water-soluble adenosine receptor antagonists and monoamine oxidase B inhibitors. |
University of Bonn |
27595538 |
36 |
Focused screening to identify new adenosine kinase inhibitors. |
University of Bonn |
30576906 |
92 |
Novel non-xanthine antagonist of the A |
Bayer Pharmaceuticals |
10737749 |
182 |
Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A(2B) adenosine receptors. |
National Institute of Diabetes |
10669571 |
24 |
Water-soluble phosphate prodrugs of 1-propargyl-8-styrylxanthine derivatives, A(2A)-selective adenosine receptor antagonists. |
University of WüRzburg |
10579811 |
70 |
Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists. |
Università |
10514293 |
31 |
Selective A(3) adenosine receptor antagonists: water-soluble 3, 5-diacyl-1,2,4-trialkylpyridinium salts and their oxidative generation from dihydropyridine precursors. |
National Institute of Diabetes |
10479279 |
20 |
N-substituted adenosines as novel neuroprotective A(1) agonists with diminished hypotensive effects. |
Novo Nordisk |
10450966 |
16 |
Discovery of FR166124, a novel water-soluble pyrazolo-[1,5-a]pyridine adenosine A1 receptor antagonist. |
Fujisawa Pharmaceutical |
10447949 |
27 |
Chiral resolution and stereospecificity of 6-phenyl-4-phenylethynyl- 1,4-dihydropyridines as selective A(3) adenosine receptor antagonists. |
National Institute of Diabetes |
10052977 |
82 |
Synthesis, CoMFA analysis, and receptor docking of 3,5-diacyl-2, 4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists. |
National Institute of Diabetes |
30605331 |
236 |
Design and in Vivo Characterization of A |
Medical College of Wisconsin |
9873431 |
18 |
The synthesis of new adenosine A3 selective ligands containing bioisosteric isoxazoles. |
Novo Nordisk |
30835463 |
202 |
A |
Rheinische Friedrich-Wilhelms-Universitat Bonn |
9667972 |
119 |
Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes. |
National Institute of Diabetes |
9622554 |
59 |
Design, synthesis, and biological evaluation of a second generation of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as potent and selective A2A adenosine receptor antagonists. |
Università |
9435909 |
90 |
Synthesis and structure-activity relationships of 3,7-dimethyl-1-propargylxanthine derivatives, A2A-selective adenosine receptor antagonists. |
Julius-Maximilians-UniversitäT WüRzburg |
9258367 |
99 |
Structure-activity relationships of 4-(phenylethynyl)-6-phenyl-1,4-dihydropyridines as highly selective A3 adenosine receptor antagonists. |
National Institute of Diabetes |
31453698 |
97 |
Antioxidant-Conjugated 1,2,4-Triazolo[4,3- |
Universit£ |
8863792 |
22 |
Synthesis and structure-activity relationship of pyrazolo[3,4-d]pyrimidines: potent and selective adenosine A1 receptor antagonists. |
Griffith University |
8863790 |
55 |
Derivatives of the triazoloquinazoline adenosine antagonist (CGS15943) are selective for the human A3 receptor subtype. |
National Institute of Diabetes |
8691445 |
70 |
Chiral pyrrolo[2,3-d]pyrimidine and pyrimido[4,5-b]indole derivatives: structure-activity relationships of potent, highly stereoselective A1-adenosine receptor antagonists. |
Julius-Maximilians-UniversitäT WüRzburg |
8676354 |
42 |
Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives: potent and selective A(2A) adenosine antagonists. |
Università |
8576921 |
63 |
Interactions of flavonoids and other phytochemicals with adenosine receptors. |
National Institute of Diabetes |
8558508 |
55 |
Tetrahydrobenzothiophenone derivatives as a novel class of adenosine receptor antagonists. |
National Institute of Diabetes |
26462195 |
29 |
2-Aminopyrimidines as dual adenosine A1/A2A antagonists. |
North-West University |
8410976 |
60 |
Effect of trifluoromethyl and other substituents on activity of xanthines at adenosine receptors. |
National Institutes of Health |
24139167 |
419 |
1,3-Dialkyl-substituted tetrahydropyrimido[1,2-f]purine-2,4-diones as multiple target drugs for the potential treatment of neurodegenerative diseases. |
University of Bonn |
7932565 |
92 |
Structure-activity relationships of 1,3-dialkylxanthine derivatives at rat A3 adenosine receptors. |
National Institute of Diabetes |
23631427 |
212 |
Dual targeting of adenosine A(2A) receptors and monoamine oxidase B by 4H-3,1-benzothiazin-4-ones. |
University of Bonn |
7731018 |
64 |
Tricyclic heteroaromatic systems. Synthesis and A1 and A2a adenosine binding activities of some 1-aryl-1,4-dihydro-3-methyl[1]benzopyrano[2,3-c] pyrazol-4-ones, 1-aryl-4,9-dihydro-3-methyl-1H-pyrazolo[3,4-b]quinolin-4- ones, and 1-aryl-1H-imidazo[4,5-b]quinoxalines. |
Università |
28835798 |
68 |
Discovery of Potent and Selective A |
Advinus Therapeutics |
29681156 |
71 |
Fluorescent-Labeled Selective Adenosine A |
University of Bonn |
28789895 |
38 |
Imidazo[1,2-?]pyridines possess adenosine A |
North-West University |
27721150 |
25 |
Selected C8 two-chain linkers enhance the adenosine A |
North-West University |
28626529 |
12 |
Photoaffinity Labeling of the Human A |
Kissei Pharmaceutical |
25684690 |
22 |
Solid-Supported Synthesis and 5-HT7 /5-HT1A Receptor Affinity of Arylpiperazinylbutyl Derivatives of 4,5-dihydro-1,2,4-triazine-6-(1H)-one. |
Jagiellonian University Medical College |